−0.33USD
−54.70 MUSD
67.50 M
About Savara, Inc.
Sector
CEO
Matthew Pauls
Headquarters
Langhorne
Website
Employees (FY)
37
Founded
1995
ISIN
US8051111016
FIGI
BBG000MS0823
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SVRA is 4.73 USD — it has decreased by 1.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Savara, Inc. stocks are traded under the ticker SVRA.
Savara, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
SVRA stock is 4.10% volatile and has beta coefficient of 1.25. Check out the list of the most volatile stocks — is Savara, Inc. there?
One year price forecast for Savara, Inc. has a max estimate of 16.00 USD and a min estimate of 6.00 USD.
SVRA earnings for the last quarter are −0.10 USD per share, whereas the estimation was −0.07 USD resulting in a −39.53% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about Savara, Inc. earnings.
Yes, you can track Savara, Inc. financials in yearly and quarterly reports right on TradingView.
SVRA stock has fallen by 10.92% compared to the previous week, the month change is a 2.67% fall, over the last year Savara, Inc. has showed a 162.78% increase.
SVRA net income for the last quarter is −16.10 M USD, while the quarter before that showed −16.60 M USD of net income which accounts for 3.01% change. Track more Savara, Inc. financial stats to get the full picture.
Today Savara, Inc. has the market capitalization of 661.73 M, it has increased by 0.21% over the last week.
No, SVRA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SVRA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Savara, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 37.00 employees. See our rating of the largest employees — is Savara, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Savara, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Savara, Inc. stock shows the neutral signal. See more of Savara, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Savara, Inc. future price: according to them, SVRA price has a max estimate of 16.00 USD and a min estimate of 6.00 USD. Read a more detailed Savara, Inc. forecast: see what analysts think of Savara, Inc. and suggest that you do with its stocks.